Advisors Asset Management, Inc.
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1297376
Monument, CO
Position in LGND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,387,168
+$756,431 QoQ
Shares Held
6,948
+108.3% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Advisors Asset Management, Inc. holds $38,396,219 across 40 Biotechnology names. LGND ranks #8 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,300 | $10,850,922 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
177,703 | $4,399,926 | |
| 3 | ASND |
Ascendis Pharma A/S
|
12,200 | $2,790,506 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,085 | $2,383,594 | |
| 5 | INCY |
Incyte Corp
|
21,594 | $2,032,427 | |
| 6 | ARQT |
Arcutis Biotherapeutics, Inc.
|
79,116 | $1,863,972 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
18,718 | $1,627,904 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
This page
|
6,948 | $1,387,168 |
All Filings in LGND
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,387,168 | 6,948 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $630,737 | 3,336 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $602,807 | 3,403 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $401,745 | 3,534 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $298,702 | 2,841 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $241,301 | 2,252 | Shares | Sole | 2025-02-10 | |
| 2023-09-30 | $414,586 | 6,919 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $508,377 | 7,051 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $522,276 | 7,100 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $481,895 | 7,214 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $404,389 | 7,528 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $440,199 | 7,909 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $917,604 | 13,076 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $870,583 | 9,035 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $614,467 | 7,070 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $586,631 | 7,168 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $684,455 | 7,197 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $455,496 | 7,342 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $348,634 | 5,863 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $271,216 | 3,887 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $156,554 | 3,451 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||